Form 4: Eli Lilly Director Ralph Alvarez Acquires Shares Through Deferral Plan

Director Ralph Alvarez of Eli Lilly & Co. acquired shares of common stock through a deferral plan, increasing his holdings.

Summary

• Ralph Alvarez, a director at Eli Lilly & Co., acquired 16,158 shares of common stock on November 18, 2024, at a price of $727.2 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan, where they were deferred in lieu of cash compensation as stock units.
• Additionally, Mr. Alvarez acquired 302.53 shares of common stock on the same day at the same price.
• Following these transactions, Mr. Alvarez's total direct holdings increased to 54,586.184 shares.
• The deferred shares will be settled in common stock after Mr. Alvarez's separation from service.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally positive as it shows director confidence, but it is not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
• The use of a deferral plan indicates a long-term commitment by the director.

Future Outlook

The deferred shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to a director's stock transactions and is common practice for publicly traded companies. It reflects the director's compensation and investment in the company.

Comparison to Industry Standards

• Director stock acquisitions are a common practice in publicly traded companies, often as part of compensation packages or through deferral plans.
• The use of stock deferral plans is a standard method for aligning director interests with long-term company performance, similar to practices at other large pharmaceutical companies such as Pfizer (PFE) and Johnson & Johnson (JNJ).

Stakeholder Impact

• The stock acquisition by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Eli Lilly, LLY, Director, Ralph Alvarez, Stock Acquisition, Deferral Plan, Share Ownership, SEC Form 4